Trial Profile
To Evaluate the safety and Pharmacokinetics of the teneligliptin in Subjects with hepatic impairment
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Teneligliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- 07 Dec 2015 Status changed from not stated to completed.
- 07 Dec 2015 New trial record